ESC Premium Access

Short-term risk of haemorrhage during heparin bridging at initiation of vitamin K antagonist therapy in patients with non-valvular atrial fibrillation managed in ambulatory care

Congress Session

About the speaker

Doctor Kim Bouillon

French National Agency for Medicines and Health Products Safety (ANSM), Saint Denis (France)
0 follower

5 more presentations in this session

Atrial fibrillation in haemodialysis patients without a vitamin K antagonist: Insight from the RAKUEN study

Speaker: Doctor W. Mitsuma (Niigata, JP)

Thumbnail

Alcohol abuse is associated with increased risk of ischemic stroke in low risk patients with non-valvular atrial fibrillation.

Speaker: Doctor F. Al-Khalili (Stockholm, SE)

Thumbnail

Do baseline characteristics account for geographical variations in event rates in patients with newly diagnosed atrial fibrillation? The GARFIELD-AF registry

Speaker: Professor K. Fox (Edinburgh, GB)

Thumbnail

Death, stroke and major bleeding risk in patients older than 85 years with atrial fibrillation

Speaker: Doctor Y. Arnson (Kfar Saba, IL)

Thumbnail

Increased use of oral anticoagulants in patients with atrial fibrillation: Nationwide temporal trends in Denmark from 2005 to 2015

Speaker: Mr K. Gadsboell (Hellerup, DK)

Thumbnail

Access the full session

Antithrombotic therapy in atrial fibrillation 1

Speakers: Doctor K. Bouillon, Doctor W. Mitsuma, Doctor F. Al-Khalili, Professor K. Fox, Doctor Y. Arnson...
Thumbnail

About the event

Image

ESC CONGRESS 2016

27 August - 31 August 2016

Sessions Presentations

This platform is supported by

logo Novo Nordisk